🎄𝐓𝐡𝐞 𝐀𝐦𝐲𝐥 𝐭𝐞𝐚𝐦 𝐰𝐢𝐬𝐡𝐞𝐬 𝐲𝐨𝐮 𝐚 𝐌𝐞𝐫𝐫𝐲 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐚𝐧𝐝 𝐚 𝐇𝐚𝐩𝐩𝐲 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫 𝟐𝟎𝟐𝟓!🎄 As 2024 is ending, we want to express our gratitude to our partners, investors, and collaborators. 2024 has been a year of challenges and major changes for us, driving innovation and progress in our research on neurodegenerative diseases. In 2025, we will push again the boundaries of science, collaborating with passionate experts, and reach our objective of a Pan Amyloid Immunotherapeutic to treat Alzheimer’s disease and other neurodegenerative disorders. Wishing you all a joyful holiday season and a new year filled with success, health, and hope. The Amyl Team ✨ #Christmas #Newyear #Challenges #Neurodegenerativediseases #innovation #progress
Amyl Therapeutics
Biotechnology Research
Liège, Walloon Region 1,444 followers
Restoring clarity in amyloid diseases
About us
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.
- Website
-
https://www.amyltx.com/
External link for Amyl Therapeutics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Liège, Walloon Region
- Type
- Privately Held
- Founded
- 2020
- Specialties
- amyloidosis, Alzheimer, Parkinson, and Biopharmaceutical research
Locations
-
Primary
Get directions
Boulevard Patience et Beaujonc
3/12
Liège, Walloon Region 4000, BE
Employees at Amyl Therapeutics
Updates
-
🚀 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐀𝐦𝐲𝐥 𝐓𝐞𝐚𝐦 ? 🚀 At Amyl Therapeutics, we're proud of the incredible people who drive our innovation every day. 🙌 Curious about who does what in our company? Check out the presentation below to get a closer look at our team. 👇 #AmylTherapeutics #Neurodegenerativediseases #Biotechnology #Innovation #MeetTheTeam
-
Over the past three days, our CEO, Pierre Vandepapelière, and our CSO, Damien TOULORGE, represented Amyl Therapeutics at #BioEurope2024 in Stockholm. They had the opportunity to exchange with industry leaders and partners on therapeutic innovations. 🤝 We are excited to strengthen our partnership and advance the future of healthcare. ✨ #BioEurope2024 #30thEdition #Innovation #Biotech #Healthcare #Leadership
-
-
Amyl is proud to represent Belgium at Bio-Europe ✨
👨🔬 #BIOEuropeFall is in full swing in Stockholm. Wallonia is out in force with 50 Belgian companies from the life sciences sector. ⚗️ Among them: Amyl Therapeutics and its new approach to neurodegenerative diseases Artialis , a spin-off from the Université de Liège specialising in musculoskeletal disorders Celyad Oncology, a specialist in cancer treatment using cell therapy CER Groupe, a research centre specialising in virology and hormonology convEyXO, which uses exosomes to treat fibrosis and chronic inflammation DeuterOncology NV, which develops targeted cancer drugs such as DO-2, a deuterated MET kinase inhibitor Estetra, a specialist in women's health with a focus on contraception and the menopause EuroscreenFast EXO Biologics , which uses exosomes to treat rare diseases including respiratory diseases, inflammatory bowel diseases, neurology and oncology EyeD Pharma, which develops ocular implants for patients suffering from glaucoma, for example Hyloris Pharmaceuticals, which reinvents drugs from existing molecules IDDI - Regulatory Statistics & Clinical Data Science Experts, providing clinical trial services to biotech and pharma companies InhaTarget Therapeutics and its innovative inhaled treatment for lung cancer Op2Lysis, which is developing drugs to lyse haematomas and blood clots formed during thrombosis in the brain The Réseau LiEU Network, which brings together the knowledge of 6 universities in Wallonia so that researchers and private and public partners can stimulate collaborations RLM Consulting , which provides regulatory affairs support at all stages of drug development Seqalis, specialising in the supply of high-quality, state-of-the-art laboratory tests and techniques, scientific consultancy and R&D services in anatomical pathology, cytogenomics and molecular biology Spectralys - Chauvin Arnoux Group, this spin-off from the Université libre de Bruxelles provides FTIR spectroscopy analysis services for biomolecules Biotech Syngulon, which develops bacteriocins THERAtRAME, which uses artificial intelligence to fight cancer UNIVERCELLS and its disruptive technologies for the production of biomolecules White Raven, a pharmaceutical subcontractor (CDMO) active in the formulation and aseptic filling of low-volume batches of injectable products 🎯 Led by Wallonia Export & Investment Agency and the health cluster in Wallonia, BioWin, this panel of companies and research players illustrates the richness of our region's ecosystem in terms of #biotechnology and pharmaceutical innovation 💊 #innovation #lifesciences #health #wallonia #invest #biotech Wallonia in Sweden
-
-
🚨Exciting News !🚨 We’re thrilled to announce that our CEO, Pierre Vandepapelière, and our CSO, Damien TOULORGE, will be attending BIO-EUROPE from November 4-6, 2024, in Stockholm ! 📍 For more info about Amyl Therapeutics, check out our brand-new website ! 🌍 https://www.amyltx.com/ #AmylTherapeutics #BioEurope #Networking #Innovation #Newwebsite #Neurodegenerativediseases
-
-
Yesterday, our team had a wonderful 𝐭𝐞𝐚𝐦 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐝𝐚𝐲 ! 🎉 We had the opportunity to 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐨𝐮𝐫 𝐛𝐨𝐧𝐝𝐬 through an urban Escape Game in the historic heart of the city of Liège. With everyone contributing to the success of the mission, it was a real 𝐭𝐞𝐚𝐦𝐰𝐨𝐫𝐤 ! 🤝 We then played the axe-throwing, where the competition was punctuated by lots of laughs ! 😄 A big thanks to the whole team for their 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 and 𝐜𝐨𝐦𝐦𝐢𝐭𝐦𝐞𝐧𝐭 ! We'd like to take this opportunity to introduce 𝐃𝐚𝐦𝐢𝐞𝐧 𝐓𝐨𝐮𝐥𝐨𝐫𝐠𝐞, 𝐨𝐮𝐫 𝐧𝐞𝐰 𝐂𝐒𝐎, who has taken over Karine Goraj's role. Karine has decided to dedicate herself to other projects, but she continues to share her experience as 𝑆𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑐 𝐴𝑑𝑣𝑖𝑠𝑜𝑟 for Amyl. Thank you Karine, for your leadership and dedication over the past 3 years ! ✨ Damien, 𝐰𝐢𝐭𝐡 𝐨𝐯𝐞𝐫 𝟏𝟓 𝐲𝐞𝐚𝐫𝐬' 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞 𝐢𝐧 𝐧𝐞𝐮𝐫𝐨𝐝𝐞𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬, brings an 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐚𝐧𝐝 𝐢𝐧𝐬𝐩𝐢𝐫𝐢𝐧𝐠 𝐯𝐢𝐬𝐢𝐨𝐧 to Amyl's projects. Welcome in the team Damien ! 🤩 #TeamBuilding #Collaboration #newCSO #neurodegenerativediseases #Innovation #AmylTherapeutics
-
-
Amyl Therapeutics is really motivated to join BioEuropeSpring to reinforce our networking with VC Funds, Pharmas and Biotechs from Europe!
🧬 #BIOEuropeSpring I Jour 1 ! La dix-huitième édition de BIO-Europe Spring a ouvert ses portes ce matin à Barcelone ! Nous vous invitons à venir échanger avec l'équipe de Bridge to Health (B2H) sur le stand de Wallonia Export & Investment Agency. Nous sommes ravis de vous accueillir aux côtés de quelques-unes des sociétés phares de notre écosystème life sciences wallon, dont certaines entreprises liégeoises telles que Amyl Therapeutics, EXO Biologics , EyeD Pharma, KiOmed Pharma, PDC*line Pharma, Q1 Scientific Belgium, QUALIblood s.a., Op2Lysis, Syngulon ou encore White Raven. 💪 Pour rencontrer notre équipe et découvrir ce que l'écosystème life sciences liégeois peut vous offrir pour créer ou développer votre entreprise, prenez rendez-vous avec Lucie Gobert👉 contact@b2h.be. 🧬 #BIOEuropeSpring | Day 1! The eighteenth edition of BIO-Europe Spring opened its doors this morning in Barcelona! We invite you to come and meet with the Bridge to Health (B2H) team at the Wallonia Export & Investment Agency booth. We are delighted to welcome you alongside some of the leading companies in our Walloon life sciences ecosystem, including companies from Liège such as Amyl Therapeutics, EXO Biologics , EyeD Pharma, KiOmed Pharma, PDC*line Pharma, Q1 Scientific Belgium, QUALIblood s.a., Op2Lysis, Syngulon, and White Raven. 💪 To meet our team and discover what the Liège life sciences ecosystem can offer you in creating or developing your business, schedule a meeting with Lucie Gobert👉 contact@b2h.be. BioWin - The Health Cluster of Wallonia
-
-
Amyl Therapetucs is joining the 2024 AD/PD conference in Lisbon to learn about progress with Immunotherapeutics targeting abeta, TAU and alpha syn and also to consolidate exciting collaborations with research and development teams involved in in vitro and ex vivo assays and models in NDD. Exciting time!